RNA therapeutics specialist MiNA Therapeutics plc has secured £23m in a Series A financing to push development its first-in-class small activating RNA (saRNA) candidates.
In October Juan Carlos Jaramillo will take over the business from Wolfgang Bender as new Chief Medical Officer and member of the Valneva Management Board.
Nine CEOs of COVID-19 vaccines have assured that safety of vaccinated individuals remains their top priority in development of the first COVID-19 vaccines.
https://european-biotechnology.com/wp-content/uploads/2024/04/Vakzine.jpg5691280Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2020-09-08 18:11:382020-09-08 18:11:38Vaccine developers unite to stand with science
/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png00Michael Kuhrt/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngMichael Kuhrt2020-09-08 08:52:002020-09-08 08:52:00EuropaBio with new Chairman
15min to detect bacterial infections – that’s what British diagnostics company FluoretiQ Ltd is offering in the fight against antimicrobial resistance. A short interview with CEO Neciah Dorh.
With around 450 attendees, the five-day digital conference particularly focused on market conditions and financing. SMEs and global partners urged for more pull incentives.
https://european-biotechnology.com/wp-content/uploads/2024/04/AMR_Conference_sponsoren_neu_kl.jpg6751200Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2020-09-01 12:33:002020-09-01 12:33:00Stakeholders push for further pull incentives
MiNA Therapeutic bags £23m financing
Latest NewsRNA therapeutics specialist MiNA Therapeutics plc has secured £23m in a Series A financing to push development its first-in-class small activating RNA (saRNA) candidates.
French Valneva appoints new CMO
AppointmentsIn October Juan Carlos Jaramillo will take over the business from Wolfgang Bender as new Chief Medical Officer and member of the Valneva Management Board.
Vaccine developers unite to stand with science
Latest NewsNine CEOs of COVID-19 vaccines have assured that safety of vaccinated individuals remains their top priority in development of the first COVID-19 vaccines.
EuropaBio with new Chairman
AppointmentsAndrew Topen is the new Chairman of the European Association for Bioindustries EuropaBio.
Scope Fluidics gets EIB loan for infection diagnostics
Latest NewsThe European Investment Bank has lend up to €10m to Polish microbial diagnostics specialist Scope Fluidics AS.
COVID-19: Roche AG launches antigen rapid test
Latest NewsRoche has announced to launch a SARS-CoV-2 point-of-care antigen test this month co-developed with SD Biosensor Inc. (South Korea).
Unilever to replace fossil carbon in cleaning products
Latest NewsUnilever has announced to invest €1bn globally to eliminate fossil fuels as a source of carbon in its cleaning products by 2030.
Interview: Neciah Dorh, CEO, FluoretiQ
Background15min to detect bacterial infections – that’s what British diagnostics company FluoretiQ Ltd is offering in the fight against antimicrobial resistance. A short interview with CEO Neciah Dorh.
Stakeholders push for further pull incentives
Latest NewsWith around 450 attendees, the five-day digital conference particularly focused on market conditions and financing. SMEs and global partners urged for more pull incentives.
Bioversys bags €17.7m financing
Latest NewsSwiss BioVersys AG has secured a CHF19m Series B financing to push clinincal development of two antiinfectives against drug-resistant pathogens.